Home > National Drug Code (NDC) > Mitoxantrone

Mitoxantrone - 63323-132-12 - (MITOXANTRONE HYDROCHLORIDE)

Alphabetical Index


Drug Information of Mitoxantrone

Product NDC: 63323-132
Proprietary Name: Mitoxantrone
Non Proprietary Name: MITOXANTRONE HYDROCHLORIDE
Active Ingredient(s): 2    mg/mL & nbsp;   MITOXANTRONE HYDROCHLORIDE
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Mitoxantrone

Product NDC: 63323-132
Labeler Name: APP Pharmaceuticals, LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA077496
Marketing Category: ANDA
Start Marketing Date: 20060411

Package Information of Mitoxantrone

Package NDC: 63323-132-12
Package Description: 1 VIAL in 1 BOX (63323-132-12) > 12.5 mL in 1 VIAL

NDC Information of Mitoxantrone

NDC Code 63323-132-12
Proprietary Name Mitoxantrone
Package Description 1 VIAL in 1 BOX (63323-132-12) > 12.5 mL in 1 VIAL
Product NDC 63323-132
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name MITOXANTRONE HYDROCHLORIDE
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20060411
Marketing Category Name ANDA
Labeler Name APP Pharmaceuticals, LLC
Substance Name MITOXANTRONE HYDROCHLORIDE
Strength Number 2
Strength Unit mg/mL
Pharmaceutical Classes Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]

Complete Information of Mitoxantrone


General Information